Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bard

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
Cancer Cell|May 18, 2011
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesisEmilie A Bard-Chapeau, Shuangwei Li, Jin Ding, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2023
In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using <sup>11</sup>C-CHDI-180R PET in a Nonhuman Primate Model of Huntington DiseaseDaniele Bertoglio, Alison R Weiss, William Liguore, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumorsEmilie A Bard-Chapeau, Justin Jeyakani, Chung H Kok, et al.
Plos One|February 8, 2014
A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's diseaseDaniel Todd, Ian Gowers, Simon J Dowler, et al.
Plos One|March 4, 2014
Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defectsEmilie A Bard-Chapeau, Dorota Szumska, Bindya Jacob, et al.
Cell Reports|June 14, 2016
RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell ReprogrammingCheng-Xu Delon Toh, Jun-Wei Chan, Zheng-Shan Chong, et al.
Cell|September 15, 2015
Systematic identification of factors for provirus silencing in embryonic stem cellsBin Xia Yang, Chadi A El Farran, Hong Chao Guo, et al.
Scientific Reports|September 10, 2021
Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidatesFrank Herrmann, Manuela Hessmann, Sabine Schaertl, et al.
Nature Communications|January 10, 2018
HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesisTingDong Yan, Wen Fong Ooi, Aditi Qamra, et al.
Journal of Medicinal Chemistry|August 5, 2021
[<sup>11</sup>C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological ProteinsLongbin Liu, Peter D Johnson, Michael E Prime, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Cancer Cell|May 18, 2011
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesisEmilie A Bard-Chapeau, Shuangwei Li, Jin Ding, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 17, 2023
In Vivo Cerebral Imaging of Mutant Huntingtin Aggregates Using <sup>11</sup>C-CHDI-180R PET in a Nonhuman Primate Model of Huntington DiseaseDaniele Bertoglio, Alison R Weiss, William Liguore, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 7, 2012
Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumorsEmilie A Bard-Chapeau, Justin Jeyakani, Chung H Kok, et al.
Plos One|February 8, 2014
A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington's diseaseDaniel Todd, Ian Gowers, Simon J Dowler, et al.
Plos One|March 4, 2014
Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defectsEmilie A Bard-Chapeau, Dorota Szumska, Bindya Jacob, et al.
Cell Reports|June 14, 2016
RNAi Reveals Phase-Specific Global Regulators of Human Somatic Cell ReprogrammingCheng-Xu Delon Toh, Jun-Wei Chan, Zheng-Shan Chong, et al.
Cell|September 15, 2015
Systematic identification of factors for provirus silencing in embryonic stem cellsBin Xia Yang, Chadi A El Farran, Hong Chao Guo, et al.
Scientific Reports|September 10, 2021
Pharmacological characterization of mutant huntingtin aggregate-directed PET imaging tracer candidatesFrank Herrmann, Manuela Hessmann, Sabine Schaertl, et al.
Nature Communications|January 10, 2018
HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesisTingDong Yan, Wen Fong Ooi, Aditi Qamra, et al.
Journal of Medicinal Chemistry|August 5, 2021
[<sup>11</sup>C]CHDI-626, a PET Tracer Candidate for Imaging Mutant Huntingtin Aggregates with Reduced Binding to AD Pathological ProteinsLongbin Liu, Peter D Johnson, Michael E Prime, et al.
Pageof 12